Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Yokota, Hajime ^a   Imai, Yasuko ^a   Tsuboko, Yusuke ^a   Tokumaru, Aya M ^a   Fujimoto, Hajime ^a   Harada, Kazumasa ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM;

AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MALE; NOCTURNAL BLOOD PRESSURE PATTERN; SCAR; CIRCADIAN RHYTHM; IMAGE ENHANCEMENT; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; ECHOCARDIOGRAPHY; FEMALE; GADOLINIUM; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 84879474951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067825     Document Type: Article

References (21)

1. Kannel WB, Gordon T, Castelli WP, Margolis JR, (1970) Electrocardiographic left ventricular Hypertrophy and risk of coronary heart disease. Ann Intern Med. 72: 813-22.
2. Kannel WB, Gordon T, Offutt D, (1969) Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 71: 89-105.
3. Sundström J, Lind L, Arnlöv J, Zethelius B, Andren B, et al. (2001) Echocardiographic and electrocardiographic diagnosis of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 103: 2346-51.
4. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, et al. (1992) The heart in hypertension. N Engl J Med. 327: 998-1008.
5. Suzuki Y, Kuwajima I, Kanemaru A, Shimosawa T, Hoshino S, et al. (1992) The cardiac functional reserve in elderly hypertensive patients with abnormal diurnal change in blood pressure. Journal of Hypertension 10: 173-179.
6. Hermida RC, Ayala DE, Mojon A, Fernandez JR, (2011) Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 58: 1165-73.
7. Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zaqrosek A, et al. (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy. J Am Coll Cardiol 53: 284-91.
8. Bruder O, Wagner A, Jensen CJ, Schneider S, Onq P, et al. (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardol 56: 875-87.
9. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, et al. (2011) Midwall fibrosis is an independent preditor of mortality in patients with aortic stenosis. J Am Coll Cardiol 58: 1271-9.
10. Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, et al. (2006) Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: The Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 48: 2285-2292.
11. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated gfr from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
12. Yokota H, Heidary S, Katikireddy CK, Nguyen P, Pauly JM, et al. (2008) Quantitative characterization of myocardial infarction by cardiac magnetic resonance imaging predicts future cardiovascular events in patients with ischemic cardiomyopathy. J Cardiovasc Magn Reson. 9: 10-17.
13. O'Sullivan C, Duggan J, Lyons S, Thornton J, Lee M, et al. (2003) Hypertensive target-organ damage in the very elderly. Hypertension. 42: 130-135.
14. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, et al. (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81: 528-536.
15. Mewton N, Liu CY, Croisille P, Croisille P, Bluemke D, et al. (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardial 57: 891-903.
16. Katholi RE, Couri DM (2011) Left ventricular hypertrophy: Major risk factor in patients with hypertension: Update and practical clinical applications. International Journal of Hypertension. doi:10.4061/2011/495349.
17. Nakatsu T, Shinohata R, Mashima K, Yuki Y, Nishitani A, et al. (2007) Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles. Hypertension Research 30: 651-658.
18. Conen D, Zeller A, Pfisterer M, Martina B, (2006) Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97: 249-52.
19. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, et al. (2007) Predictors of all-cause mortality in clinical ambulatory monitoring. Hypertension 49: 1235-1241.
20. Kwon DH, Smedira NG, Rodriguez ER, Tan C, Setser R, et al. (2009) Cardiac magnetic resonance detection of myocardial scaring in hypertrophic cardiomyopathy. J Am Coll Cardial 54: 242-9.
21. Maceira AM, Mohiaddin RH, (2012) Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson. 14: 28.